Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. allergy asthma triggers
Show results for

Refine by
Date

  • Older

Allergy Asthma Triggers Articles & Analysis: Older

22 news found

Intrommune Therapeutics Completes Enrollment in the Phase 1 OMEGA Study for Peanut Allergy

Intrommune Therapeutics Completes Enrollment in the Phase 1 OMEGA Study for Peanut Allergy

Observed only mild and transient adverse events, with no use of emergency epinephrine Observed 98.4% patient compliance to date with novel OMIT therapeutic modality Safely started patients on dose 4, potentially reducing the time to reach maintenance by several weeks NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based, clinical stage biotechnology ...

ByIntrommune Therapeutics


Uncomfortable Conditions, Mold, and Dust Mites Can All Result from Elevated Indoor Humidity Levels

Uncomfortable Conditions, Mold, and Dust Mites Can All Result from Elevated Indoor Humidity Levels

High humidity levels could even result in the presence of large numbers of dust mites indoors which, like indoor mold, can trigger allergies and even asthma attacks in some people with the condition. ...

ByCochrane & Associates, LLC


Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy

Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy

NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based, clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, today announced an amendment to its ongoing Phase 1 OMEGA Clinical Study of INT301 in adult patients with peanut allergy. The amendment increases the study duration for patients to 48 ...

ByIntrommune Therapeutics


Intrommune Therapeutics Names Nandini Murthy as Head of Regulatory

Intrommune Therapeutics Names Nandini Murthy as Head of Regulatory

NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based, clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, announced the addition of Nandini Murthy as Head of Regulatory. “Ms. Murthy has proven to be an invaluable asset to Intrommune since joining the organization as a consultant ...

ByIntrommune Therapeutics


The Essential Guide to Food Allergies

The Essential Guide to Food Allergies

Food Allergy Research and Education (FARE) has established that more than 32 million people in the US are victims of food allergy. Almost 8% of children with a food allergy are less than 5 years old and overall 4% of adults suffer from food allergies. Research conducted by NIH shows that more than 3.24% people in France have different types of food allergies. The study also shows that there is an ...

ByHYCOR Biomedical


Hidden Allergens in Christmas meals

Hidden Allergens in Christmas meals

Wines, for instance, if they are not ecologically sourced, might contain sulfites, a preservative that grape growers dust over grapes in the weeks leading up to harvest. Sulfites can trigger allergy-like reactions to sensitized people, such as wheezing in those suffering from asthma, allergic rhinitis, and urticaria[3]. ...

ByHYCOR Biomedical


Covid-19 or Seasonal Allergy: How to differentiate?

Covid-19 or Seasonal Allergy: How to differentiate?

Unlike COVID-19, seasonal allergies aren't caused by a virus. Seasonal allergies are immune system responses triggered by exposure to allergens, such as seasonal tree or grass pollens. ...

ByHYCOR Biomedical


INT301 Continues to Meet Safety Goals in Phase 1 OMEGA Study in Adults with Peanut Allergy While Reaching Phase 2 Target Maintenance Dose

INT301 Continues to Meet Safety Goals in Phase 1 OMEGA Study in Adults with Peanut Allergy While Reaching Phase 2 Target Maintenance Dose

NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based, clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, today announced that its ongoing Phase 1 OMEGA Clinical Study of INT301 in adult patients with peanut allergy has been amended to allow determination of the Maximum Tolerated Dose ...

ByIntrommune Therapeutics


Intrommune Therapeutics Names Sergi X. Trilla, MD, MBA as its Director, Corporate Strategy & Partnerships

Intrommune Therapeutics Names Sergi X. Trilla, MD, MBA as its Director, Corporate Strategy & Partnerships

NEW YORK, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based, clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, announced the promotion of Sergi Trilla, MD to become Director of Corporate Strategy & Partnerships. “Dr. Trilla has proven to be an invaluable asset to Intrommune since he ...

ByIntrommune Therapeutics


Intrommune Therapeutics Launches #PeanutAllergyStrong

Intrommune Therapeutics Launches #PeanutAllergyStrong

NEW YORK, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based, clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, announced the launch of its #PeanutAllergyStrong patient engagement campaign. “Supporting peanut allergy patients and their loved ones has always been the central mission at ...

ByIntrommune Therapeutics


Intrommune Therapeutics to Present at BIO Digital 2021

Intrommune Therapeutics to Present at BIO Digital 2021

NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, announced today that it will be presenting at BIO Digital 2021. The event will be live June 10-11 & 14-18, 2021. Michael Nelson, JD, Co-Founder and CEO will provide an overview of ...

ByIntrommune Therapeutics


EPA Announces Proposed Updates to List of Pests of Significant Health Importance

EPA Announces Proposed Updates to List of Pests of Significant Health Importance

Draft PR Notice 2020-X describes the groups of pests and their potential impact on public health as follows: Arthropods: The listed arthropods may cause asthma or trigger allergies, contaminate food, irritate skin, cause direct injury, or carry diseases such as epidemic typhus, trench fever, epidemic relapsing fever, malaria, encephalitis (St. ...

ByBergeson & Campbell, P.C.


Cockroach Allergens & Asthma Triggers Discussed in New Video

Cockroach Allergens & Asthma Triggers Discussed in New Video

Their newest production discusses how the presence of cockroaches in an indoor environment can cause allergies and trigger asthma attacks in some people. The U.S. Environmental Protection Agency (EPA) reports, “Droppings or body parts of cockroaches and other pests can trigger asthma. Certain proteins are ...

ByCochrane & Associates, LLC


NIH Statement on World Asthma Day 2015

Within a broad asthma research portfolio, NIH-supported scientists are making progress in understanding how certain exposures—such as to microbes, allergy-triggering substances (allergens) and pollution—may contribute to the development or worsening of asthma, and are working on new approaches to address these ...

ByNational Institute of Environmental Health Sciences (NIEHS)


Puerto Rico’s IEQ Experts Identify Allergy & Asthma Triggers Caused by Dust Mites

Puerto Rico’s IEQ Experts Identify Allergy & Asthma Triggers Caused by Dust Mites

“Dust mites do not bite people, but their body parts and droppings can cause allergic reactions and trigger asthma in individuals who are sensitive to exposure,” said Harry Pena, President of Zimmetry Environmental. “Children being exposed to dust mites is believed to be an important factor in causing asthma in children who ...

ByCochrane & Associates, LLC


Could Dust Mites be Triggering Your Allergies or Asthma?

Could Dust Mites be Triggering Your Allergies or Asthma?

Lurking in ordinary house dust is one of the most common causes of allergies. Dust mites can be found in most homes and a single gram of house dust may have hundreds or even thousands of dust mites in it. ...

ByEMSL Analytical, Inc.


Dust Mites, Allergies & Asthma Discussed in New Online Video

Dust Mites, Allergies & Asthma Discussed in New Online Video

Their latest educational video discusses health issues associated dust mites and their connection to indoor allergies and their ability to trigger asthma attacks. One of the most common causes of allergies to house dust is due to the presence of dust mites. ...

ByCochrane & Associates, LLC


Indoor Allergies & Asthma Triggers Identified with IAQ Index

Indoor Allergies & Asthma Triggers Identified with IAQ Index

Less air makes its way to the lungs and the body’s own mucous can further clog the airways. An asthma attack can happen when a susceptible individual is exposed to an “asthma triggers.” These triggers can vary among asthma suffers. According to the U.S. Centers for Disease Control and ...

ByCochrane & Associates, LLC


Illinois Department of Health Takes Aim at Mold and People’s Health

Illinois Department of Health Takes Aim at Mold and People’s Health

Many people don’t realize it can take as little as 24 to 48 hours for mold to begin to grow indoors when moisture is present in a structure. Mold is also a known asthma trigger. For people with asthma it is all the more important that the air they breathe in their homes, offices and schools is free of elevated levels of mold.” ...

ByCochrane & Associates, LLC


Six Cleveland Area Hotels Become the First Residence Inn by Marriott Properties in Ohio to Feature PURE Allergy Friendly Rooms

Six Cleveland Area Hotels Become the First Residence Inn by Marriott Properties in Ohio to Feature PURE Allergy Friendly Rooms

These ultra-comfortable accommodations are enjoyed by all guests, but bring an extra level of relief to asthma and allergy sufferers by providing the cleanest, freshest air for a more restful sleep during their stay. ...

ByPure Solutions

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT